Dr. Savin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Knight Cancer Institute, Oregon Health & Science University
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-5672Fax+1 503-494-4285
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 1975
- Duke University HospitalResidency, Internal Medicine, 1973
- Duke University HospitalInternship, Internal Medicine, 1969 - 1970
- University of Pittsburgh School of MedicineClass of 1969
- Harvard UniversityA.B., History and Science, Cum Laude, 1965
Certifications & Licensure
- MO State Medical License 2020 - 2024
- NY State Medical License 1978 - 2023
- OR State Medical License 2014 - 2023
- CA State Medical License 1975 - 2022
- TX State Medical License 1987 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- US Oncology Research Honor for Enrolling Over 100 Patients 14th Annual Science Forum, 2015
- Regional Top Doctor Castle Connolly, 2014
- Oncology Top Doctors by Sally Giddens The Magazine of Dallas, 1992
- Join now to see all
Clinical Trials
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
- A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma Start of enrollment: 2011 Aug 01
- Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies Start of enrollment: 2013 Mar 14
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsMechanical Thrombectomy in Pulmonary Embolism Associated with COVID-19: A "Clotography" Gallery.Dinu V. Balanescu, Herman S. Kado, Amy Mertens, Rajat Chand, Michael Savin
Vascular and Endovascular Surgery. 2021-08-06 - 2 citationsAdo-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab.Luai Al Rabadi, Madeline Cook, Andy Kaempf, Megan M. Saraceni, Michael A. Savin
BMC Cancer. 2021-04-06 - 34 citationsEverolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy.Madeline Cook, Luai Al Rabadi, Andy Kaempf, Megan M. Saraceni, Michael A. Savin
The Oncologist. 2021-02-01
Journal Articles
- Quantitative measurement of HER2 expression in breast cancers: comparison with ‘real-world’ routine HER2 testing in a multicenter Collaborative Biomarker...Yardley DA, Kaufman PA, Huang W, Krekow L, Savin MA, Lawler WE, Zrada S, Starr A, Einhorn H, Schwartzberg LS, Adams JW, Lie Y, Paquet AC, Sperinde J,..., Breast Cancer Research, 1/1/2015
- A Phase II Study of Eribulin Mesylate (E7389) in Patients With Advanced, Previously-Treated Non-Small Cell Lung CancerSpira AI, Iannotti NO, Savin MA, Neubauer M, Gabrail NY, Yanagihara RH, Zang EA, Cole PE, Shuster D, Das A, Clinical Lung Cancer, 1/1/2012
- Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7- Year Follow-Up of US Oncology Researc...Jones S, Holmes FA, O’Shaughnessy J, Blum JL, Vukelja SJ, McIntyre KJ, Pippen JE, Bordelon JH, Kirby RL, Sandbach J, Hyman WJ, Richards DA, Mennel RG, Boehm KA, Meyer ..., Journal of Clinical Oncology, 1/1/2009
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Scalp Cooling Alopecia Prevention Trial (SCALP) for Patients with Early Stage Breast CancerNangia JR, Wang, T Rude, M Osborne, C Papish, M Abraham, J, Holmes F, Savin M, Paxman R, Hilsenbeck SG, Osborne K, Rimawi MF, ASCO 2016 Annual Meeting, 1/1/2016
- Abstract OT3-02-08: Scalp cooling alopecia prevention trial (SCALP) for patients with early stage breast cancerNangia JR, Wang T, Rude M, Osborne C, Papish M, Abraham J, Holmes F, Savin M, Paxman R, Hilsenbeck SG, Osborne K, Rimawi MF, Ongoing Trials-Chemotherapy, San Antonio Breast Cancer Symposium, 1/1/2015
- Quantitative measurement of HER2 expression in breast cancers: comparison with “real world” testing in a multi-center Collaborative Biomarker Study (CBS) and correlati...Yardley DA, Kaufman PA, Adams JW, Krekow L, Savin, M, Lawler WE, Zrada S, Starr A, Einhorn H, Schwartzberg LS, Huang W, Weidler J, Lie Y, Paquet A, Haddad M,..., 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 1/1/2012
- Join now to see all
Press Mentions
- Dr. Michael Savin, M.D., Has Been Recognized as One of America's Most Influential Physicians by the International Association of Who's WhoNovember 15th, 2019
- The Leading Physicians of the World Will Be Displaying Distinguished Hematologist and Oncologist, Michael A. Savin, MDSeptember 27th, 2017
- Venerated Oncologist Michael A. Savin, MD, Will Be Highlighted in the Leading Physicians of the WorldOctober 6th, 2016
Other Languages
- Spanish, German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: